Nasal microbiome could help predict recurrent polyps in chronic rhinosinusitis patients with more than 90 percent accuracy, revealed a recent study by Dr Yan Zhao and team at Capital Medical University, Beijing, based on data from 85 individuals. Chronic rhinosinusitis with nasal polyps (CRSwNP) has a significant impact on patient quality of life. However the underlying mechanism of the disease has not been well studied, and treatment options remain limited. The researchers, in their paper, published in Allergy, suggested that features of the nasal microbiome can predict the recurrence of nasal polyps after endoscopic sinus surgery and serve as a potential treatment target.